V-WAVE is a pioneering brand that focuses on advancing the flow of life for patients with chronic heart failure. Established in Israel in 2009, V-WAVE specializes in developing percutaneous implantable technologies to provide relief for heart failure patients. Their flagship product, the Ventura® Interatrial Shunt System, is designed to alleviate symptoms, reduce hospitalizations, and improve the quality of life for those living with heart failure.

With offices in Caesarea, Israel, and Agoura Hills, California, V-WAVE is a privately held company that combines science, engineering, and medicine to bring unique ideas and technologies to patients. Their dedicated team, led by CEO Neal Eigler, MD, is committed to offering new therapy options to patients with heart failure and cardiovascular disease. Since their inception, V-WAVE has been at the forefront of innovation.

Their interatrial shunt devices, implanted through minimally invasive catheter-based procedures, lower left atrial pressure and improve clinical outcomes. Continuous research and design improvements have led to high rates of device implantation success, excellent safety, and relief of symptoms. V-WAVE's mission is to provide hope and relief to the millions of individuals living with heart failure and cardiovascular disease worldwide.

Through their dedication to advancing the field of heart failure treatment, V-WAVE is changing the lives of patients and redefining the future of cardiac care